|
|
| | Latanoprost amide Basic information |
| Product Name: | Latanoprost amide | | Synonyms: | Latanoprost amide;5-Heptenamide, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-, (5Z)-;(5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]-5-heptenamide | | CAS: | 919281-21-3 | | MF: | C23H35NO4 | | MW: | 389.53 | | EINECS: | | | Product Categories: | | | Mol File: | 919281-21-3.mol |  |
| | Latanoprost amide Chemical Properties |
| Boiling point | 629.9±55.0 °C(Predicted) | | density | 1.136±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 100 mg/ml,DMSO: 50 mg/ml,Ethanol: 100 mg/ml,PBS (pH 7.2): 0.05mg/ml | | form | An oil | | pka | 14.84±0.70(Predicted) |
| | Latanoprost amide Usage And Synthesis |
| Uses | Latanoprost amide is a derivative of the F-prostaglandin (FP) receptor agonist Latanoprost (HY-B0577)[1]. | | References | [1] Pauly A, et al. In vitro and in vivo comparative toxicological study of a new preservative-free latanoprost formulation. Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8172-80. DOI:10.1167/iovs.12-10766 |
| | Latanoprost amide Preparation Products And Raw materials |
|